+91-22-48913909
ഫിൻ‌കാഷ് »മ്യൂച്വൽ ഫണ്ടുകൾ »2018 ലെ മികച്ച പ്രകടന മേഖല ഫണ്ടുകൾ
Table of Contents
- പ്രകടനത്തെ അടിസ്ഥാനമാക്കി 2019 ലെ മികച്ച 10 പെർഫോർമിംഗ് സെക്ടർ മ്യൂച്വൽ ഫണ്ടുകൾ
- 2019 ലെ മികച്ച പ്രകടന മേഖല ഫണ്ടുകൾ
Top 10 Equity - Sectoral Funds
2019 ലെ മികച്ച 10 പെർഫോർമിംഗ് സെക്ടർ ഫണ്ടുകൾ
മേഖലമ്യൂച്വൽ ഫണ്ടുകൾ ഒരു പ്രത്യേക മേഖലയിലെ കമ്പനികളുടെ ഇക്വിറ്റി ഷെയറുകളിൽ അവരുടെ ഫണ്ട് പണത്തിന്റെ പ്രധാന പങ്ക് നിക്ഷേപിക്കുന്ന സ്കീമിനെ കാണുക. ഈ സ്കീമുകൾ അന്വേഷിക്കുന്ന വ്യക്തികൾ അന്വേഷിക്കുന്നുഉയർന്ന വരുമാനം അവരുടെ നിക്ഷേപത്തിൽ aഉയർന്ന അപകടസാധ്യത വിശപ്പ്. മ്യൂച്വൽ ഫണ്ടുകൾ സാധാരണയായി അവരുടെ സ്കീമുകൾ വാഗ്ദാനം ചെയ്യുന്ന ചില മേഖലകളിൽ അടിസ്ഥാന സ, കര്യങ്ങൾ, ഫാർമസ്യൂട്ടിക്കൽ, ബാങ്കിംഗ്, ധനകാര്യ സേവനങ്ങൾ, പ്രകൃതിവിഭവങ്ങൾ, പുതിയ .ർജ്ജം എന്നിവ ഉൾപ്പെടുന്നു. 2019 ലെ മേഖലാ ഫണ്ടുകളുടെ പ്രകടനം ഗണ്യമായി മികച്ചതാണ്. സമ്പദ്‌വ്യവസ്ഥയിലെ സംഭവവികാസങ്ങളോടെ, പല മേഖലാ ഫണ്ടുകളും അവരുടെ നിക്ഷേപങ്ങളിൽ നല്ല വരുമാനം നേടി. അതിനാൽ, 2019 ലെ മികച്ചതും മികച്ചതുമായ 10 പെർഫോമൻസ് സെക്ടർ മ്യൂച്വൽ ഫണ്ടുകളിൽ ചിലത് അവരുടെ പ്രകടനത്തിന്റെ അടിസ്ഥാനത്തിൽ (വരുമാനം) നോക്കാം.
Talk to our investment specialist
പ്രകടനത്തെ അടിസ്ഥാനമാക്കി 2019 ലെ മികച്ച 10 പെർഫോർമിംഗ് സെക്ടർ മ്യൂച്വൽ ഫണ്ടുകൾ
Fund NAV Net Assets (Cr) 2024 (%) 2023 (%) 2022 (%) 2021 (%) 2020 (%) LIC MF Infrastructure Fund Growth ₹44.3812
↓ -0.61 ₹927 47.8 44.4 7.9 46.6 -0.1 UTI Healthcare Fund Growth ₹278.669
↓ -0.79 ₹1,236 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹426.614
↓ -0.19 ₹3,628 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹29.9964
↓ -0.15 ₹1,287 40.4 36.6 -8 19.1 64.4 IDFC Infrastructure Fund Growth ₹46.519
↓ -0.15 ₹1,791 39.3 50.3 1.7 64.8 6.3 Franklin India Opportunities Fund Growth ₹237.796
↓ -0.53 ₹6,120 37.3 53.6 -1.9 29.7 27.3 L&T Business Cycles Fund Growth ₹39.1025
↓ -0.13 ₹1,035 36.3 31.3 5.3 34.5 9.3 Canara Robeco Infrastructure Growth ₹142.43
↓ -0.15 ₹872 35.3 41.2 9 56.1 9 Nippon India Pharma Fund Growth ₹497.027
↓ -0.66 ₹8,915 34 39.2 -9.9 23.9 66.4 Invesco India Infrastructure Fund Growth ₹58.46
↑ 0.08 ₹1,606 33.2 51.1 2.3 55.4 16.2 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 7 Feb 25
2019 ലെ മികച്ച പ്രകടന മേഖല ഫണ്ടുകൾ
The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The investment objective of the scheme is to seek to generate long-term capital growth through an active diversified portfolio of predominantly equity and equity related instruments of companies that are participating in and benefiting from growth in Indian infrastructure and infrastructural related activities. However, there can be no assurance that the investment objective of the scheme will be realized. IDFC Infrastructure Fund is a Equity - Sectoral fund was launched on 8 Mar 11. It is a fund with High risk and has given a Below is the key information for IDFC Infrastructure Fund Returns up to 1 year are on The investment objective of Franklin India Opportunities Fund (FIOF) is to generate capital appreciation by capitalizing on the long-term growth opportunities in the Indian economy. Franklin India Opportunities Fund is a Equity - Sectoral fund was launched on 21 Feb 00. It is a fund with Moderately High risk and has given a Below is the key information for Franklin India Opportunities Fund Returns up to 1 year are on To seek to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related securities, including equity derivatives, in the Indian market with focus on riding business cycles through dynamic allocation between various sectors and stocks at different stages of business cycles in the economy L&T Business Cycles Fund is a Equity - Sectoral fund was launched on 20 Aug 14. It is a fund with Moderately High risk and has given a Below is the key information for L&T Business Cycles Fund Returns up to 1 year are on T o g e n e r a t e income/capital appreciation by investing in equities and equity related instruments of companies in the infrastructure sector. However, there can be no assurance that the investment objective of the scheme will be realized. Canara Robeco Infrastructure is a Equity - Sectoral fund was launched on 2 Dec 05. It is a fund with High risk and has given a Below is the key information for Canara Robeco Infrastructure Returns up to 1 year are on The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies. Nippon India Pharma Fund is a Equity - Sectoral fund was launched on 5 Jun 04. It is a fund with High risk and has given a Below is the key information for Nippon India Pharma Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of infrastructure companies. However, there can be no assurance that the investment objective of the Scheme will be achieved. Invesco India Infrastructure Fund is a Equity - Sectoral fund was launched on 21 Nov 07. It is a fund with High risk and has given a Below is the key information for Invesco India Infrastructure Fund Returns up to 1 year are on 1. LIC MF Infrastructure Fund
CAGR/Annualized return of 9.2% since its launch. Return for 2024 was 47.8% , 2023 was 44.4% and 2022 was 7.9% . LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (07 Feb 25) ₹44.3812 ↓ -0.61 (-1.35 %) Net Assets (Cr) ₹927 on 31 Dec 24 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.3 Sharpe Ratio 2.11 Information Ratio 1.13 Alpha Ratio 26.65 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jan 20 ₹10,000 31 Jan 21 ₹9,834 31 Jan 22 ₹14,762 31 Jan 23 ₹15,309 31 Jan 24 ₹24,273 31 Jan 25 ₹30,162 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 7 Feb 25 Duration Returns 1 Month -13.6% 3 Month -13.3% 6 Month -11.9% 1 Year 18.4% 3 Year 25.2% 5 Year 23.6% 10 Year 15 Year Since launch 9.2% Historical performance (Yearly) on absolute basis
Year Returns 2024 47.8% 2023 44.4% 2022 7.9% 2021 46.6% 2020 -0.1% 2019 13.3% 2018 -14.6% 2017 42.2% 2016 -2.2% 2015 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.38 Yr. Mahesh Bendre 1 Jul 24 0.59 Yr. Data below for LIC MF Infrastructure Fund as on 31 Dec 24
Equity Sector Allocation
Sector Value Industrials 50.6% Basic Materials 11.02% Consumer Cyclical 9.84% Utility 7.43% Financial Services 6.38% Technology 3.93% Real Estate 1.91% Communication Services 1.88% Energy 1.29% Health Care 0.2% Asset Allocation
Asset Class Value Cash 5.52% Equity 94.48% Top Securities Holdings / Portfolio
Name Holding Value Quantity Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006555% ₹43 Cr 86,410 Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP5% ₹42 Cr 391,152 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | 5329553% ₹26 Cr 525,720 Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | SCHNEIDER3% ₹25 Cr 328,026 GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 5222753% ₹25 Cr 120,063 Bharat Bijlee Ltd (Industrials)
Equity, Since 31 Jul 22 | BBL2% ₹22 Cr 59,231
↑ 7,625 Tata Power Co Ltd (Utilities)
Equity, Since 29 Feb 24 | 5004002% ₹22 Cr 554,470
↑ 80,934 Cummins India Ltd (Industrials)
Equity, Since 31 May 21 | 5004802% ₹22 Cr 66,145 ISGEC Heavy Engineering Ltd (Industrials)
Equity, Since 31 Jul 24 | 5330332% ₹22 Cr 149,711 Bharat Forge Ltd (Consumer Cyclical)
Equity, Since 30 Sep 21 | 5004932% ₹21 Cr 158,209
↑ 48,733 2. UTI Healthcare Fund
CAGR/Annualized return of 15.1% since its launch. Ranked 40 in Sectoral category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (07 Feb 25) ₹278.669 ↓ -0.79 (-0.28 %) Net Assets (Cr) ₹1,236 on 31 Dec 24 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 2.32 Information Ratio -0.22 Alpha Ratio -0.45 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jan 20 ₹10,000 31 Jan 21 ₹15,455 31 Jan 22 ₹17,925 31 Jan 23 ₹16,531 31 Jan 24 ₹24,618 31 Jan 25 ₹30,793 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 7 Feb 25 Duration Returns 1 Month -5.4% 3 Month -3.3% 6 Month 5.5% 1 Year 26.3% 3 Year 20.9% 5 Year 25.3% 10 Year 15 Year Since launch 15.1% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.9% 2023 38.2% 2022 -12.3% 2021 19.1% 2020 67.4% 2019 1.2% 2018 -7.5% 2017 6.2% 2016 -9.7% 2015 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 2.76 Yr. Data below for UTI Healthcare Fund as on 31 Dec 24
Equity Sector Allocation
Sector Value Health Care 96.03% Basic Materials 1.27% Financial Services 0.29% Asset Allocation
Asset Class Value Cash 2.41% Equity 97.59% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA11% ₹137 Cr 725,000 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 5000876% ₹71 Cr 464,949
↑ 14,289 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY5% ₹65 Cr 470,234 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | 5323315% ₹57 Cr 193,047 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | 5322964% ₹50 Cr 309,311 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND4% ₹47 Cr 266,306 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP4% ₹44 Cr 60,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | 5328433% ₹40 Cr 557,701
↓ -53,957 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL3% ₹39 Cr 74,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB3% ₹37 Cr 61,480 3. SBI Healthcare Opportunities Fund
CAGR/Annualized return of 15.9% since its launch. Ranked 34 in Sectoral category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (06 Feb 25) ₹426.614 ↓ -0.19 (-0.04 %) Net Assets (Cr) ₹3,628 on 31 Dec 24 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 2.76 Information Ratio 0.52 Alpha Ratio 4.09 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jan 20 ₹10,000 31 Jan 21 ₹15,535 31 Jan 22 ₹17,594 31 Jan 23 ₹17,709 31 Jan 24 ₹26,160 31 Jan 25 ₹33,176 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 7 Feb 25 Duration Returns 1 Month -2.4% 3 Month -0.4% 6 Month 12.6% 1 Year 27.2% 3 Year 24% 5 Year 27.6% 10 Year 15 Year Since launch 15.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 42.2% 2023 38.2% 2022 -6% 2021 20.1% 2020 65.8% 2019 -0.5% 2018 -9.9% 2017 2.1% 2016 -14% 2015 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 13.68 Yr. Pradeep Kesavan 31 Dec 23 1.09 Yr. Data below for SBI Healthcare Opportunities Fund as on 31 Dec 24
Equity Sector Allocation
Sector Value Health Care 90.04% Basic Materials 6.53% Asset Allocation
Asset Class Value Cash 3.35% Equity 96.57% Debt 0.08% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA13% ₹472 Cr 2,500,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH6% ₹226 Cr 2,000,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB6% ₹220 Cr 360,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | 5000876% ₹214 Cr 1,400,000
↑ 120,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | 5002575% ₹188 Cr 800,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY4% ₹151 Cr 300,000 Mankind Pharma Ltd (Healthcare)
Equity, Since 30 Apr 23 | MANKIND4% ₹151 Cr 523,016
↑ 123,016 Poly Medicure Ltd (Healthcare)
Equity, Since 31 Aug 24 | POLYMED4% ₹131 Cr 500,000 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5433083% ₹126 Cr 2,100,000
↓ -100,000 Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | JLHL3% ₹125 Cr 800,000
↓ -32,871 4. TATA India Pharma & Healthcare Fund
CAGR/Annualized return of 12.8% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (07 Feb 25) ₹29.9964 ↓ -0.15 (-0.50 %) Net Assets (Cr) ₹1,287 on 31 Dec 24 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 2.2 Information Ratio 0.61 Alpha Ratio 4.02 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jan 20 ₹10,000 31 Jan 21 ₹15,073 31 Jan 22 ₹17,565 31 Jan 23 ₹16,932 31 Jan 24 ₹24,972 31 Jan 25 ₹30,507 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 7 Feb 25 Duration Returns 1 Month -5.4% 3 Month -1.9% 6 Month 2.1% 1 Year 22.3% 3 Year 21% 5 Year 24.9% 10 Year 15 Year Since launch 12.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 40.4% 2023 36.6% 2022 -8% 2021 19.1% 2020 64.4% 2019 5.5% 2018 -2.6% 2017 4.7% 2016 -14.7% 2015 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Meeta Shetty 9 Mar 21 3.9 Yr. Rajat Srivastava 16 Sep 24 0.38 Yr. Data below for TATA India Pharma & Healthcare Fund as on 31 Dec 24
Equity Sector Allocation
Sector Value Health Care 92.85% Basic Materials 2.06% Asset Allocation
Asset Class Value Cash 5.1% Equity 94.9% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA12% ₹152 Cr 804,300 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA8% ₹99 Cr 741,000 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | 5002578% ₹97 Cr 410,240 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | DRREDDY7% ₹85 Cr 614,555 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | 5000876% ₹75 Cr 490,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB5% ₹64 Cr 104,965 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | 5328435% ₹62 Cr 855,100 Zydus Lifesciences Ltd (Healthcare)
Equity, Since 31 Dec 22 | 5323214% ₹46 Cr 471,287 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP3% ₹43 Cr 58,903 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM3% ₹42 Cr 75,249 5. IDFC Infrastructure Fund
CAGR/Annualized return of 11.7% since its launch. Ranked 1 in Sectoral category. Return for 2024 was 39.3% , 2023 was 50.3% and 2022 was 1.7% . IDFC Infrastructure Fund
Growth Launch Date 8 Mar 11 NAV (07 Feb 25) ₹46.519 ↓ -0.15 (-0.32 %) Net Assets (Cr) ₹1,791 on 31 Dec 24 Category Equity - Sectoral AMC IDFC Asset Management Company Limited Rating ☆☆☆☆☆ Risk High Expense Ratio 2.33 Sharpe Ratio 1.59 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-365 Days (1%),365 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jan 20 ₹10,000 31 Jan 21 ₹10,449 31 Jan 22 ₹16,786 31 Jan 23 ₹16,915 31 Jan 24 ₹28,172 31 Jan 25 ₹32,572 Returns for IDFC Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 7 Feb 25 Duration Returns 1 Month -10% 3 Month -12.3% 6 Month -15.8% 1 Year 12.5% 3 Year 23.7% 5 Year 26.4% 10 Year 15 Year Since launch 11.7% Historical performance (Yearly) on absolute basis
Year Returns 2024 39.3% 2023 50.3% 2022 1.7% 2021 64.8% 2020 6.3% 2019 -5.3% 2018 -25.9% 2017 58.7% 2016 10.7% 2015 -0.2% Fund Manager information for IDFC Infrastructure Fund
Name Since Tenure Vishal Biraia 24 Jan 24 1.02 Yr. Ritika Behera 7 Oct 23 1.32 Yr. Gaurav Satra 7 Jun 24 0.65 Yr. Data below for IDFC Infrastructure Fund as on 31 Dec 24
Equity Sector Allocation
Sector Value Industrials 58.01% Utility 12.35% Basic Materials 8.64% Technology 4.18% Communication Services 3.82% Financial Services 3.21% Energy 3.07% Consumer Cyclical 2.58% Health Care 1.77% Asset Allocation
Asset Class Value Cash 2.38% Equity 97.62% Top Securities Holdings / Portfolio
Name Holding Value Quantity Kirloskar Brothers Ltd (Industrials)
Equity, Since 31 Dec 17 | KIRLOSBROS5% ₹92 Cr 443,385 GPT Infraprojects Ltd (Industrials)
Equity, Since 30 Nov 17 | GPTINFRA4% ₹68 Cr 4,797,143 Larsen & Toubro Ltd (Industrials)
Equity, Since 29 Feb 12 | LT3% ₹62 Cr 171,447 KEC International Ltd (Industrials)
Equity, Since 30 Jun 24 | 5327143% ₹57 Cr 475,362 Reliance Industries Ltd (Energy)
Equity, Since 30 Jun 24 | RELIANCE3% ₹55 Cr 452,706 UltraTech Cement Ltd (Basic Materials)
Equity, Since 31 Mar 14 | 5325383% ₹54 Cr 46,976 Adani Ports & Special Economic Zone Ltd (Industrials)
Equity, Since 31 Dec 23 | ADANIPORTS3% ₹54 Cr 434,979 PTC India Financial Services Ltd (Financial Services)
Equity, Since 31 Dec 23 | PFS3% ₹53 Cr 12,400,122 H.G. Infra Engineering Ltd Ordinary Shares (Industrials)
Equity, Since 28 Feb 18 | HGINFRA3% ₹49 Cr 321,984 Ahluwalia Contracts (India) Ltd (Industrials)
Equity, Since 30 Apr 15 | AHLUCONT3% ₹48 Cr 470,125 6. Franklin India Opportunities Fund
CAGR/Annualized return of 13.5% since its launch. Ranked 47 in Sectoral category. Return for 2024 was 37.3% , 2023 was 53.6% and 2022 was -1.9% . Franklin India Opportunities Fund
Growth Launch Date 21 Feb 00 NAV (07 Feb 25) ₹237.796 ↓ -0.53 (-0.22 %) Net Assets (Cr) ₹6,120 on 31 Dec 24 Category Equity - Sectoral AMC Franklin Templeton Asst Mgmt(IND)Pvt Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 2.12 Sharpe Ratio 1.98 Information Ratio 1.47 Alpha Ratio 17.76 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jan 20 ₹10,000 31 Jan 21 ₹12,591 31 Jan 22 ₹15,887 31 Jan 23 ₹15,681 31 Jan 24 ₹26,031 31 Jan 25 ₹31,795 Returns for Franklin India Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 7 Feb 25 Duration Returns 1 Month -5.2% 3 Month -4.9% 6 Month -3.2% 1 Year 22.1% 3 Year 26.8% 5 Year 25.8% 10 Year 15 Year Since launch 13.5% Historical performance (Yearly) on absolute basis
Year Returns 2024 37.3% 2023 53.6% 2022 -1.9% 2021 29.7% 2020 27.3% 2019 5.4% 2018 -10.1% 2017 35.6% 2016 4.2% 2015 2.3% Fund Manager information for Franklin India Opportunities Fund
Name Since Tenure Kiran Sebastian 7 Feb 22 2.99 Yr. R. Janakiraman 1 Apr 13 11.85 Yr. Sandeep Manam 18 Oct 21 3.29 Yr. Data below for Franklin India Opportunities Fund as on 31 Dec 24
Equity Sector Allocation
Sector Value Consumer Cyclical 19.42% Health Care 13.81% Financial Services 11.43% Industrials 10.29% Communication Services 10.06% Technology 7.7% Basic Materials 5.08% Consumer Defensive 3.31% Real Estate 2.83% Energy 2.22% Utility 1.96% Asset Allocation
Asset Class Value Cash 10.36% Equity 89.64% Top Securities Holdings / Portfolio
Name Holding Value Quantity Bharti Airtel Ltd (Communication Services)
Equity, Since 31 Jan 24 | BHARTIARTL3% ₹213 Cr 1,342,233 Zomato Ltd (Consumer Cyclical)
Equity, Since 31 Aug 23 | 5433203% ₹211 Cr 7,590,491 Mahindra & Mahindra Ltd (Consumer Cyclical)
Equity, Since 31 May 24 | M&M3% ₹192 Cr 637,966 HDFC Bank Ltd (Financial Services)
Equity, Since 31 May 24 | HDFCBANK3% ₹188 Cr 1,058,931
↓ -500,163 Info Edge (India) Ltd (Communication Services)
Equity, Since 31 Jul 24 | NAUKRI3% ₹188 Cr 216,138 PB Fintech Ltd (Financial Services)
Equity, Since 30 Nov 21 | 5433903% ₹176 Cr 833,638 Lemon Tree Hotels Ltd (Consumer Cyclical)
Equity, Since 31 Aug 24 | LEMONTREE3% ₹168 Cr 10,951,216 Aster DM Healthcare Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Aug 23 | ASTERDM3% ₹157 Cr 3,049,105 APL Apollo Tubes Ltd (Basic Materials)
Equity, Since 31 Oct 24 | APLAPOLLO3% ₹154 Cr 981,985
↑ 448,634 Sudarshan Chemical Industries Ltd (Basic Materials)
Equity, Since 30 Apr 24 | SUDARSCHEM2% ₹149 Cr 1,303,298 7. L&T Business Cycles Fund
CAGR/Annualized return of 13.9% since its launch. Ranked 19 in Sectoral category. Return for 2024 was 36.3% , 2023 was 31.3% and 2022 was 5.3% . L&T Business Cycles Fund
Growth Launch Date 20 Aug 14 NAV (07 Feb 25) ₹39.1025 ↓ -0.13 (-0.32 %) Net Assets (Cr) ₹1,035 on 31 Dec 24 Category Equity - Sectoral AMC L&T Investment Management Ltd Rating ☆☆☆☆ Risk Moderately High Expense Ratio 2.43 Sharpe Ratio 2.1 Information Ratio 1.38 Alpha Ratio 17.48 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-18 Months (1%),18 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jan 20 ₹10,000 31 Jan 21 ₹10,352 31 Jan 22 ₹14,177 31 Jan 23 ₹14,608 31 Jan 24 ₹20,563 31 Jan 25 ₹24,256 Returns for L&T Business Cycles Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 7 Feb 25 Duration Returns 1 Month -8.9% 3 Month -9.7% 6 Month -4.1% 1 Year 15.7% 3 Year 19.3% 5 Year 19% 10 Year 15 Year Since launch 13.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 36.3% 2023 31.3% 2022 5.3% 2021 34.5% 2020 9.3% 2019 5.3% 2018 -17.5% 2017 45.6% 2016 3.2% 2015 3.5% Fund Manager information for L&T Business Cycles Fund
Name Since Tenure Venugopal Manghat 20 Aug 14 10.46 Yr. Gautam Bhupal 1 Jun 23 1.67 Yr. Sonal Gupta 1 Jun 23 1.67 Yr. Data below for L&T Business Cycles Fund as on 31 Dec 24
Equity Sector Allocation
Sector Value Industrials 28.98% Financial Services 28.42% Consumer Cyclical 17.44% Basic Materials 12.29% Energy 5.7% Real Estate 1.2% Technology 1.13% Asset Allocation
Asset Class Value Cash 3.67% Equity 96.33% Top Securities Holdings / Portfolio
Name Holding Value Quantity Trent Ltd (Consumer Cyclical)
Equity, Since 31 Dec 16 | 5002517% ₹68 Cr 95,680
↓ -5,000 Multi Commodity Exchange of India Ltd (Financial Services)
Equity, Since 31 Dec 22 | MCX6% ₹59 Cr 94,300 ICICI Bank Ltd (Financial Services)
Equity, Since 31 Aug 14 | ICICIBANK5% ₹54 Cr 425,000 Reliance Industries Ltd (Energy)
Equity, Since 31 Aug 18 | RELIANCE3% ₹35 Cr 290,400 HDFC Bank Ltd (Financial Services)
Equity, Since 31 Aug 14 | HDFCBANK3% ₹34 Cr 193,300 PB Fintech Ltd (Financial Services)
Equity, Since 31 Dec 23 | 5433903% ₹31 Cr 149,200 Larsen & Toubro Ltd (Industrials)
Equity, Since 31 Aug 14 | LT3% ₹30 Cr 81,830 Bharat Electronics Ltd (Industrials)
Equity, Since 31 Dec 22 | BEL3% ₹29 Cr 1,000,000 Ahluwalia Contracts (India) Ltd (Industrials)
Equity, Since 31 Jan 15 | AHLUCONT3% ₹28 Cr 274,908 Power Finance Corp Ltd (Financial Services)
Equity, Since 31 Jan 24 | 5328103% ₹27 Cr 603,200 8. Canara Robeco Infrastructure
CAGR/Annualized return of 14.9% since its launch. Return for 2024 was 35.3% , 2023 was 41.2% and 2022 was 9% . Canara Robeco Infrastructure
Growth Launch Date 2 Dec 05 NAV (07 Feb 25) ₹142.43 ↓ -0.15 (-0.11 %) Net Assets (Cr) ₹872 on 31 Dec 24 Category Equity - Sectoral AMC Canara Robeco Asset Management Co. Ltd. Rating Risk High Expense Ratio 2.47 Sharpe Ratio 1.58 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jan 20 ₹10,000 31 Jan 21 ₹10,828 31 Jan 22 ₹16,760 31 Jan 23 ₹17,573 31 Jan 24 ₹26,441 31 Jan 25 ₹31,645 Returns for Canara Robeco Infrastructure
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 7 Feb 25 Duration Returns 1 Month -9.1% 3 Month -11.5% 6 Month -11% 1 Year 15.4% 3 Year 22.5% 5 Year 24.7% 10 Year 15 Year Since launch 14.9% Historical performance (Yearly) on absolute basis
Year Returns 2024 35.3% 2023 41.2% 2022 9% 2021 56.1% 2020 9% 2019 2.3% 2018 -19.1% 2017 40.2% 2016 2.1% 2015 6.7% Fund Manager information for Canara Robeco Infrastructure
Name Since Tenure Vishal Mishra 26 Jun 21 3.6 Yr. Shridatta Bhandwaldar 29 Sep 18 6.35 Yr. Data below for Canara Robeco Infrastructure as on 31 Dec 24
Equity Sector Allocation
Sector Value Industrials 49.89% Utility 13.18% Technology 7.58% Energy 7.45% Financial Services 5.82% Basic Materials 5.48% Communication Services 3.03% Real Estate 1.78% Consumer Cyclical 1.62% Asset Allocation
Asset Class Value Cash 4.16% Equity 95.84% Top Securities Holdings / Portfolio
Name Holding Value Quantity Larsen & Toubro Ltd (Industrials)
Equity, Since 28 Feb 11 | LT6% ₹52 Cr 143,401
↑ 20,000 NTPC Ltd (Utilities)
Equity, Since 30 Nov 18 | 5325554% ₹38 Cr 1,131,666 Dixon Technologies (India) Ltd (Technology)
Equity, Since 31 Oct 23 | DIXON4% ₹31 Cr 17,450 Hitachi Energy India Ltd Ordinary Shares (Technology)
Equity, Since 31 Aug 23 | POWERINDIA4% ₹31 Cr 21,500 Power Grid Corp Of India Ltd (Utilities)
Equity, Since 31 Oct 09 | 5328983% ₹30 Cr 977,546 Reliance Industries Ltd (Energy)
Equity, Since 30 Apr 22 | RELIANCE3% ₹30 Cr 244,750 Kaynes Technology India Ltd (Industrials)
Equity, Since 31 Mar 23 | KAYNES3% ₹28 Cr 38,000 Tata Power Co Ltd (Utilities)
Equity, Since 30 Sep 24 | 5004003% ₹28 Cr 710,000
↑ 60,000 InterGlobe Aviation Ltd (Industrials)
Equity, Since 31 Jan 23 | INDIGO3% ₹27 Cr 60,250
↑ 6,250 Bharti Airtel Ltd (Communication Services)
Equity, Since 31 May 24 | BHARTIARTL3% ₹26 Cr 166,100 9. Nippon India Pharma Fund
CAGR/Annualized return of 20.8% since its launch. Ranked 35 in Sectoral category. Return for 2024 was 34% , 2023 was 39.2% and 2022 was -9.9% . Nippon India Pharma Fund
Growth Launch Date 5 Jun 04 NAV (07 Feb 25) ₹497.027 ↓ -0.66 (-0.13 %) Net Assets (Cr) ₹8,915 on 31 Dec 24 Category Equity - Sectoral AMC Nippon Life Asset Management Ltd. Rating ☆☆ Risk High Expense Ratio 1.88 Sharpe Ratio 2.01 Information Ratio -0.58 Alpha Ratio -3.65 Min Investment 5,000 Min SIP Investment 100 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jan 20 ₹10,000 31 Jan 21 ₹15,604 31 Jan 22 ₹18,346 31 Jan 23 ₹17,643 31 Jan 24 ₹26,687 31 Jan 25 ₹30,762 Returns for Nippon India Pharma Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 7 Feb 25 Duration Returns 1 Month -6.2% 3 Month -3.4% 6 Month 0.2% 1 Year 16% 3 Year 20.2% 5 Year 25.2% 10 Year 15 Year Since launch 20.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 34% 2023 39.2% 2022 -9.9% 2021 23.9% 2020 66.4% 2019 1.7% 2018 3.6% 2017 7.6% 2016 -10.6% 2015 19.4% Fund Manager information for Nippon India Pharma Fund
Name Since Tenure Sailesh Raj Bhan 1 Apr 05 19.85 Yr. Kinjal Desai 25 May 18 6.7 Yr. Data below for Nippon India Pharma Fund as on 31 Dec 24
Equity Sector Allocation
Sector Value Health Care 98.14% Asset Allocation
Asset Class Value Cash 1.86% Equity 98.14% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMA14% ₹1,237 Cr 6,556,349 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB9% ₹824 Cr 1,350,808 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | 5002578% ₹755 Cr 3,203,676 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | DRREDDY6% ₹508 Cr 3,662,170 Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | 5000875% ₹474 Cr 3,100,000 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Sep 20 | APOLLOHOSP5% ₹473 Cr 648,795 Vijaya Diagnostic Centre Ltd (Healthcare)
Equity, Since 30 Sep 21 | 5433504% ₹320 Cr 3,025,298 Medplus Health Services Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5434273% ₹296 Cr 3,564,680 Ajanta Pharma Ltd (Healthcare)
Equity, Since 30 Apr 22 | 5323313% ₹281 Cr 959,323 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND3% ₹267 Cr 1,500,000 10. Invesco India Infrastructure Fund
CAGR/Annualized return of 10.8% since its launch. Ranked 24 in Sectoral category. Return for 2024 was 33.2% , 2023 was 51.1% and 2022 was 2.3% . Invesco India Infrastructure Fund
Growth Launch Date 21 Nov 07 NAV (07 Feb 25) ₹58.46 ↑ 0.08 (0.14 %) Net Assets (Cr) ₹1,606 on 31 Dec 24 Category Equity - Sectoral AMC Invesco Asset Management (India) Private Ltd Rating ☆☆☆ Risk High Expense Ratio 2.34 Sharpe Ratio 1.58 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Jan 20 ₹10,000 31 Jan 21 ₹10,943 31 Jan 22 ₹16,865 31 Jan 23 ₹17,187 31 Jan 24 ₹28,001 31 Jan 25 ₹32,256 Returns for Invesco India Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 7 Feb 25 Duration Returns 1 Month -9.8% 3 Month -10.7% 6 Month -11.9% 1 Year 9.3% 3 Year 22.7% 5 Year 25.2% 10 Year 15 Year Since launch 10.8% Historical performance (Yearly) on absolute basis
Year Returns 2024 33.2% 2023 51.1% 2022 2.3% 2021 55.4% 2020 16.2% 2019 6.1% 2018 -15.8% 2017 48.1% 2016 0.8% 2015 -2.6% Fund Manager information for Invesco India Infrastructure Fund
Name Since Tenure Amit Nigam 3 Sep 20 4.42 Yr. Data below for Invesco India Infrastructure Fund as on 31 Dec 24
Equity Sector Allocation
Sector Value Industrials 58.17% Utility 9.67% Consumer Cyclical 8.7% Basic Materials 6.73% Technology 4.65% Health Care 3.44% Financial Services 2.05% Energy 2.04% Real Estate 1.62% Communication Services 1% Asset Allocation
Asset Class Value Cash 1.93% Equity 98.07% Top Securities Holdings / Portfolio
Name Holding Value Quantity Larsen & Toubro Ltd (Industrials)
Equity, Since 29 Feb 12 | LT5% ₹79 Cr 218,263
↓ -18,991 Power Grid Corp Of India Ltd (Utilities)
Equity, Since 30 Apr 22 | 5328984% ₹72 Cr 2,318,884
↓ -39,834 Jyoti CNC Automation Ltd (Industrials)
Equity, Since 31 Jan 24 | JYOTICNC4% ₹61 Cr 452,265
↓ -7,835 Bharat Electronics Ltd (Industrials)
Equity, Since 30 Nov 17 | BEL3% ₹50 Cr 1,717,480 BEML Ltd (Industrials)
Equity, Since 31 May 23 | 5000483% ₹48 Cr 119,030 KEI Industries Ltd (Industrials)
Equity, Since 30 Sep 19 | KEI3% ₹48 Cr 108,188 Hindustan Aeronautics Ltd Ordinary Shares (Industrials)
Equity, Since 30 Nov 22 | HAL3% ₹47 Cr 112,968 Transformers & Rectifiers (India) Ltd (Industrials)
Equity, Since 30 Jun 24 | TARIL3% ₹47 Cr 409,648 PTC Industries Ltd (Industrials)
Equity, Since 30 Sep 24 | 5390063% ₹45 Cr 33,553 Dixon Technologies (India) Ltd (Technology)
Equity, Since 30 Sep 22 | DIXON3% ₹45 Cr 24,993
ഇവിടെ നൽകിയിരിക്കുന്ന വിവരങ്ങൾ കൃത്യമാണെന്ന് ഉറപ്പാക്കാൻ എല്ലാ ശ്രമങ്ങളും നടത്തി. എന്നിരുന്നാലും, ഡാറ്റയുടെ കൃത്യത സംബന്ധിച്ച് ഒരു ഉറപ്പുമില്ല. നിക്ഷേപം നടത്തുന്നതിന് മുമ്പ് ദയവായി സ്കീം വിവര പ്രമാണം ഉപയോഗിച്ച് പരിശോധിക്കുക.
You Might Also Like
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved